Acute respiratory infection: first clinical manifestation of active infection with cytomegalovirus in HIV patients presenting to the emergency department
1 Emergency Department, Hospital Clínic, Barcelona, Spain
2 Microbiology Department, Hospital Clínic, Centro de investigación internacional (CRESIB) Hospital Clínic, Universidad de Barcelona, Barcelona, Spain
3 Infectious diseases, Hospital Clinic, IDIBAPS, Universidad de Barcelona, Barcelona, Spain
DOI: 10.22514/SV121.102016.19 Vol.12,Issue S1,October 2016 pp.111-115
Published: 10 October 2016
Introduction. Traditionally, digestive and ophthalmic symptoms have been described as predominant in the clinical presentation of active infection with cytomegalovirus (AICMV). Nevertheless, it seems that this has changed following the introduction of antiretroviral therapy (ART). Nowadays, respiratory infection (RI) in HIV-infected patients is the first reason for consulting an Emergency Department (ED). Among these patients, the mortality is important.
Aim. To determine if RI in HIV-infected patients is a common manifestation of AI-CMV and to describe the changes in clini-cal presentation of AICMV in relation to what was previously described.
Methods. A single-center, retrospective study was conducted over the duration of nine years (2005-2015). All HIV patients who consulted our emergency depart-ment with respiratory symptoms and were diagnosed with AICMV were included. Isolation of other co-infecting microor-ganisms and mortality in the series are also described.
Results. 56 HIV-infected patients with AI-CMV were identified. RI was diagnosed in 34 (61%), 31(91%) patients had pneu-monia and 3(9%) pulmonary tuberculosis. The most frequently isolated microorgan-ism was P. jirovecii, in 21 (68%) patients. Bacteria were isolated in five patients (15%). Five patients died from RI (9%). No patient had acute retinitis or any other ophthalmic involvement.
Conclusion. Clinical manifestation of AI-CMV in HIV patients has changed, and RI is the most common manifestation, caused by opportunistic microorganisms with 9% mortality.
HIV, infection respiratory, pneu-monia, CMV
PERELLÓ R,VERGARA A,CAMÓN S,SAUBI N,ETO Y,QUIRÓS C,PRIU I,MORENO A,MARTÍNEZ E,MARCOS MA. Acute respiratory infection: first clinical manifestation of active infection with cytomegalovirus in HIV patients presenting to the emergency department. Signa Vitae. 2016. 12(S1);111-115.
1. Sanbonmatsu Gámez S, Ruiz MP, Navarro Marí JM. Infection by human cytomegalovirus. Enferm Infecc Microbiol Clin 2014;32:15-22.
2. Komdewall MJ, Mollema L, Tchermieva I, Van der Klis F, Kroes AC, Qudesluys-Murphy AM, et al. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. J Clin Virol 2015;63:53-8.
3. Bowen EF, Griffiths PD, Davey CC, Emery VC, Johnson MA. Lessons from the natural history of cytomegalovirus. AIDS 1996;10:S37-41.
4. Crum NF, Riffenburg RH, Wegner S, Agan BK, Tasker SA, Spooner KM, et al. Comparisons of causes of death and mortality rates aamong HIV-infected persons: analysis of the pre-, early, and late HAART eras. J Acquir Defic Syndrom 2006;11:194-200.
5. Camón S, Perelló R, Escoda O, Escoda R, Aguilar N, Saubi N, et al. (2014) Reason for HIV Patients Consultation to the Emergency Department in the HAART Era: Incidence and Mortality. J AIDS Clin Res 5:340.
6. Perelló R, Escoda O, Camón S, Miró Ò, Castañeda M, Moreno A, et al. Changes in the etiology, incidence and prognosis of acute respiratory track infections, in human immunodeficiency virus patients. Enferm Infecc Microbiol Clin 2015;33:243-7.
7. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, et al. Transplantation Society International CMV Con-sensus Group. Update international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2013;96:333-60.
8. Torre-Cisneros J, Fariñas MC, Castón J.J, Aguado J.M, Cantisán S, Carratalá J, et al.GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enferm Infecc Microbiol Clin 2011;29:735-58.
9. Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998;26:811-38.
10. Ojha CR, Rijal N, Khagendra KC, Palpasa K, Kansakar P, Gupta BP, et al. Lower respiratory tract infections among HIV positive and control group in Nepal. Virus disease 2015;26:77-81.
11. Cilloniz C, Torres A, Polverino E, Gabarrus A, Amaro R, Moreno E, et al. Community-accquired respiratory infections in HIV-infected patients: microbioal aetiology and outcome. Eur Respir J 2014;43:1698-708.
12. Katsidzira L, Fana GT, Makunike-Mutasa R, Ferrand RA. Pneumomediastinum in an HIV-infected patient with cytomegalovirus pneumonitis. Int J STD AIDS 2011;3:179-80.
13. WHO fact sheet on tuberculosis (TB) [Online]. October 2015. Reviewed March 2016; Available from: URL:http://www.who.int/mediacentre/factsheets/fs104/en/ Fact sheet N8104.
14. Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, et al. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial. Lancet 2016;387:1198-209.
15. Podlasin RB. CMV infection in HIV-patients. Przegl Epidemiol 2007;61:629-37.
16. Whitcup SM. Cytomegalovirus retinitis in the era of highly active antirretroviral therapy. JAMA 2000;283:653-7.
17. Papazian L, Hraiech S, Lehingue S, Roch A, Chiche L, Wiramus S. Cytomegalovirus reactivation in ICU patients. Intensive Care Med 2016:42:28-37.
18. Lichtner M, Cicconi P, Vita S, Cozzi-Lepri A, Galli M, Lo Caputo S, et al. Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. J Infect Dis 2015;211:178-86.
19. Boulougoura A, Sereti I. HIV infection and immune activation: the role of coinfections. Curr Opin HIV AIDS 2016;11:191-200.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 0.5(2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.